Company / SG&A Expense
bioAffinity Technologies, Inc. SG&A Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$9.9M
FY2025
5-year range
$1.1M / $9.9M
FY2022-FY2025
Trend
+46.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 3 consecutive years, from $1M in FY2022 to $10M in FY2025.
Based on SEC 10-K filings.
$10M in FY2025 with a 3-year CAGR of +110.3%.
Increased from $2M to $10M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +110.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- bioAffinity Technologies, Inc.'s sg&a expense has grown for 3 consecutive years.
- 3-year CAGR of +110.3%, indicating consistent growth.
- In FY2025, sg&a expense increased 46.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.9M | +46.4% |
| FY2024 | $6.8M | +173.7% |
| FY2023 | $2.5M | +132.1% |
| FY2022 | $1.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026